Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay

Completed

Conditions studied: HIV

In brief

The purpose of this study was to evaluate the performance of the Bio-Rad Geenius HIV 1/2 Supplemental Assay, a single-use immunochromatographic assay for the confirmation and differentiation of individual antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) in fingerstick whole blood, venous whole blood, serum, or plasma samples (EDTA, heparin, and sodium citrate).

Key facts

Study ID

NCT02401555

Run by

Bio-Rad Laboratories

People needed

419

Starts

2013-04-01

Expected to finish

2013-12-01

Last updated by the study team

2017-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• HIV/AIDS Division, San Fransisco General Hospital — San Francisco, California, United States
• Blood Systems Research Institute — San Francisco, California, United States
• Center for Disease Control and Prevention — Atlanta, Georgia, United States
• Clinical Trials Center, Walter Reed Army Institute of Research — Silver Spring, Maryland, United States
• University Of Washington AIDS Clinical Trials Unit, Harborview Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.